文献速递血栓与止血

皇家病的高级细胞模型:突变F9 mRNA的特征分析

Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.
PubMed 文献 · J Thromb Haemost · 2017-09-25

研究利用携带F9 c.278-3A>G突变的血友病B患者及其母亲的皮肤成纤维细胞建立诱导多能干细胞(iPSC)模型,并分化为肝细胞样细胞(HLC)。下一代测序显示患者HLC中F9 mRNA水平显著低于其母亲,证实内含子突变导致异常剪接、移码和提前终止密码子,并提示无义介导的衰变(NMD)降解突变转录本;同时检测到少量正确剪接的转录本。

要点

  • 患者来源iPSC分化的肝细胞样细胞中F9 mRNA水平显著低于其母亲。
  • F9 c.278-3A>G突变导致F9转录本异常剪接、移码和提前终止密码子。
  • 患者肝细胞样细胞中检测到少量正确剪接的转录本,可能部分解释临床变异。

核心结论

  • 本研究首次建立了血友病B的真正细胞模型,可在RNA水平研究罕见突变,并展示了F9基因内含子突变的病理后果。

研究设计与样本

  • 利用携带F9 c.278-3A>G突变的血友病B患者及其母亲的皮肤活检成纤维细胞生成诱导多能干细胞(iPSC),并分化为肝细胞样细胞(HLC),用下一代测序(NGS)分析F9 mRNA。

主要发现

  • 患者HLC中F9 mRNA水平显著低于其母亲,提示突变转录本经历无义介导的衰变(NMD)。
  • 证实了内含子核苷酸替换导致F9转录本异常剪接、移码和提前终止密码子(PTC)的预测。
  • 在患者HLC中检测到少量正确剪接的转录本,结合剪接和NMD机制的遗传变异性,可能部分解释欧洲皇室受影响成员寿命高于平均的临床变异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials The Royal disease (RD) is a form of hemophilia B predicted to be caused by a splicing mutation. We generated an iPSC-based model of the disease allowing mechanistic studies at the RNA level. F9 mRNA analysis in iPSC-derived hepatocyte-like cells showed the predicted abnormal splicing. Mutated F9 mRNA level was very low but we also found traces of wild type transcripts. SUMMARY: Background The royal disease is a form of hemophilia B (HB) that affected many descendants of Queen Victoria in the 19th and 20th centuries. It was found to be caused by the mutation F9 c.278-3A>G. Objective To generate a physiological cell model of the disease and to study F9 expression at the RNA level. Methods Using fibroblasts from skin biopsies of a previously identified hemophilic patient bearing the F9 c.278-3A>G mutation and his mother, we generated induced pluripotent stem cells (iPSCs). Both the patient's and mother's iPSCs were differentiated into hepatocyte-like cells (HLCs) and their F9 mRNA was analyzed using next-generation sequencing (NGS). Results and Conclusion We demonstrated the previously predicted aberrant splicing of the F9 transcript as a result of an intronic nucleotide substitution leading to a frameshift and the generation of a premature termination codon (PTC). The F9 mRNA level in the patient's HLCs was significantly reduced compared with that of his mother, suggesting that mutated transcripts undergo nonsense-mediated decay (NMD), a cellular mechanism that degrades PTC-containing mRNAs. We also detected small proportions of correctly spliced transcripts in the patient's HLCs, which, combined with genetic variability in splicing and NMD machineries, could partially explain some clinical variability among affected members of the European royal families who had lifespans above the average. This work allowed the demonstration of the pathologic consequences of an intronic mutation in the F9 gene and represents the first bona fide cellular model of HB allowing the study of rare mutations at the RNA level.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Martorell L, Luce E, Vazquez JL, et al. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA. J Thromb Haemost. 2017. PMID: 28834196. doi:10.1111/jth.13808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。